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A monoclonal antibody (9C4) shows that an [Na’+K’]coupled glutamate transporter protein purified from rat brain runs electrophoretically as 
a wide band and is localized in neuroglial cell bodies and processes, but not in neurons. This confirms the findings with polyclonal antibodies 
[Neuroscience 51 (1992) 295-3101, and shows that the apparent heterogeneity in relative molecular mass is accounted for by a single antigenic 
epitope. By testing several synthetic peptides derived from the deduced amino acid sequences of two cloned rat brain glutamate transporters, the 
antigenic epitope was identified as residing within the peptide TQSVYDDTKNHRESNSNQC (residues 518-536) of one of these wature 360 (1992) 
4644671. 
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1. INTRODUCTION 
The high affinity uptake system for the neurotrans- 
mitter glutamate mediates electrogenic cotransport of 
this amino acid with sodium and potassium (the latter 
moving outwards) [l]. Since glutamate is considered to 
be the major excitatory transmitter in brain [2-51, this 
transport system is of particular importance. It appears 
to be the mechanism by which synaptically released 
excitatory amino acids are inactivated [6] and kept 
below toxic levels in the extracellular space [7-91; thus 
impaired uptake in pathological conditions may lead to 
cell damage [lO-131. 
In this study we have raised a monoclonal antibody 
against the purified 73 kDa polypeptide [14,15] and we 
have synthesized 12 peptides based on the sequences of 
the two cloned rat brain glial glutamate transporters 
reported to date [16,17]. With these tools we demon- 
strate that (1) recognition of a single epitope is sufficient 
to account for the broad electrophoretic band charac- 
teristic of the 73 kDa polypeptide; (2) the 73 kDa pol- 
ypeptide is indeed localized in glia cells, including their 
fine processes. 
2. MATERIALS AND METHODS 
Recently we have reported on the purification of a 
glutamate transporter [14], and its identification and 
localization in brain by polyclonal antibodies raised 
against the purified protein [15]. By screening a cDNA 
library with these antibodies, a glutamate transporter 
has been cloned [16]. However, these polyclonal anti- 
bodies labelled a wide band upon electrophoresis and 
immunoblotting of detergent extracts of rat brain. It 
might therefore be argued that they recognize more than 
one protein. If so, the study on the localization [15] of 
the transporter would be equivocal. 
2.1. Aniigen purification and polyclonal antibodies 
Purification of a glutamate transporter was done as described 
[14,15]. The purest fraction (the peak fraction from the DEAE-cellu- 
lose column) was further purified by preparative lectrophoresis, di- 
alysed against water, lyophihzed and stored at -20°C until used as 
described [15]. The polyclonal antibodies [15] were obtained by immu- 
nizing a rabbit with this protein and affinity purifying the ensuing IgG 
on a column with immobilized deglycosylated antigen. Protein was 
determined as described [18], when necessary after rapid gel filtration 
to remove interfering substances [14]. Sodium dodecyl sulphate-ex- 
tracts from whole rat brains were prepared as described [15]. 
2.2. Inzmzuzzzation 
Correspondence address: N.C. Danbolt, Anatomical Institute, Univer- 
sity of Oslo, P.O.Box 1105, Bhndern, N-0317 Oslo Norway. Fax: (47) 
(2) 85 12 78. 
Abbrevzatzons: BSA, bovine serum albumin; DEAE, diethylami- 
noethyl; ELISA, enzyme linked immunosorbent assay; GAT, GABA 
transporter; GLAST and GLT, two different glutamate transporters; 
GLYT, glycine transporter; GNA, Galanthus nivahs lectin; HEPES, 
4-(2-hydroxyethyl)-l-piperazineethanesulfonic ac d; PROT, proline 
transporter; PMSF, phenylmethanesulfonyl fluoride; TBST, 10 mM 
Tris-HCI pH 8.0, 150 mM NaCI, 8 mM NaN,, 0.05% Tween 20. 
5Opg of the above lyophilized protein was dissolved in 0.2 ml water, 
emulsified with 0.3 ml complete Freund’s adjuvant and injected in- 
traperitoneally into a Balb/c male mouse. Three more immunizations 
with the antigen in Freund’s incomplete adjuvant were performed at 
intervals of about one month. After the second and third immuniza- 
tions, the mice were bled and the serum was tested on immunoblots 
containing sodium dodecyl sulphate-extracted brain proteins. 
2.3. Generation and selection of hybridoma cell lines 
The mouse with the highest iter was given a fourth injection. Four 
days later the spleen cells were collected. The activated lymphocytes 
were enriched on a two-step discontinuous Percoll gradient (35% Per- 
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co11 in Fl and 51% Percoll m F2) to increase the rate of producing 
hybridomas [19,20]. Mouse myeloma cells (NSO) were fused with 
spleen cells at a 1:l ratio, using polyethyleneglycol as described [21]. 
After fusion. the cells were cultured in Iscove’s modified Dulbecco’s 
medium supplemented with hypoxanthine, thymidine, aminopterin 
and 20% fetal calf serum on a feeder layer of peritoneal macrophages 
from Balb-c mice. Positive clones were selected after 8-10 days (using 
the ELISA test system described below) and subcloned in medium 
without aminopterin. After the second subcloning, strongly positive 
clones were mass cultured. Ascites was induced in Balb-c mice. Both 
supematants and ascites were tested on Western blots and on ELISA. 
Commercial kits were used to determine immunoglobulin class (The 
Binding Site, Bi~ingh~, UK; Sigma, St. Louis. MO). 
2.4. ELISA 
All incubations were performed on a horizontat shaker at room 
temp. Each well in 96wells polystyrene tissue culture plates was incu- 
bated (2 h) with 25 ~1 of the peak fraction from the DEAE-cellulose 
column [14] (diluted 1 + 2 with water; protein concentration: 25-50 
pg/ml) and blocked (2 h) with 300 ~1 of 20% newborn calf serum in 
TBST (150 mM NaCl, 0.05% v/v Tween 20, 10 mM Tris-HCl pH 8.0. 
8 mM NaN,) followed by incubation (1 h) with 50~1 supcrnatant and 
washing with TBST (6 cycles of 50 seconds). Bound antibodies were 
detected with alkaline phosphatase-conjugated rabbit anti-mouse IgG 
(Promega, Madison, WI) diluted 1:lOOO in 20% (v/v) newborn calf 
serum in TBST (SO@, 1 h). Washing in TBST (6 cycles of 50 seconds) 
was followed by addition of 200~1~-nitrophenyl phosphate (1 mglmlf 
in 0.1 M sodium glycine pH 10.4 with I mM MgC& and ZnC&. The 
OD,, was measured after 20, 60 and 120 minutes. 
2.5. Electrophoresis und ~mmunablotting 
Sodium dodecyl sulphate-polyacrylamide g l electrophoresis was 
done as described [14, 221. After electrophoresis the proteins were 
either silver stained [14] or blotted onto mtrocellulose membranes as 
described [23] and briefly rinsed m TBST. After blocking (60 min) of 
unspecific binding sites with blocking solution (BSA 10 mg/ml in 
TBST), the nitrocellulose was incubated (overnight. room temp.) with 
antibodies in new blocking solution. Affinity-purified rabbit IgG anti- 
glutamate transporter antibodies [15] were used at 50 ng/ml while 
purified IgM 9C4 antibodies were used at 100 &ml when not stated 
otherwise. Cell culture supernatants were diluted 1 + 1 with 2 x block- 
tng solution. Bound antibodies were detected with anti-rabbit 1gG 
(200 n&ml; Promega, Madison, WI) or anti-mouse Ig conJugated to 
alkaline phosphatase (ZOO @ml; Promega, Madison, WI). 
2.6. Purtjkation of mouse IgM from ascites 
A 2 ml column (bed height 25 mm) of Galanthus nivulis (GNA) lectin 
immobilized on agarose beads (E-Y Laboratories, San Mateo, CA) 
was equilibrated (at 4°C) with starting buffer (150 mM NaCI, 10 mM 
sodium-HEPES pH 7.5). 1.2 ml ascites was applied to the column 
(flow rate 15 ml/h). Subsequently, the column was closed for 60 min 
and then washed with 12 ml starting buffer (flow rate 120 ml/h). Bound 
IgM was eluted with 6 ml 0.2 M a-mannose in starting buffer (flow 
rate 3-6 ml/h) and concentrated by ultrafiltration. 
2.7. Synthettc peptzdes und cou@ng fo ovaibl~mi~ 
Peptides were obtained 80-95% pure (as determined by HPLC) 
either from the Centre of Biot~hnolo~ (Oslo, Norway) or from 
Multiple Peptide Systems (San Diego. CA). All the peptides (see leg- 
end to Fig. 2 for details) except GLYT and GATl were obtained as 
carboxy-terminal mides. The peptides were coupled to ovalbumin as 
described [24]: I ml 2% glutaraldehyde was added to 1 ml ovalbumin 
(1 mg/ml) and peptide (1 mg/ml) in 0.15 M NaCl and 0. I M sodmm- 
HEPES pH 7.4. After incubation (60 min. 4°C continuous stirring) 
sodium borohydride (10 mg/ml) was added. The mixture was mcu- 
bated (60 min. 4°C). dialysed against 0.1 M sodium phosphate buffer 
pH 7.4, spotted on nitrocellulose, dried and incubated with antibody 
(see ‘immunoblotting’ above, legend Fig. 2 and ‘Immunocytochemts- 
try’ below). 
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2.8. Imm~~oc~toche~zistr~ 
Rats were perfusion-fixed and the tissue was subsequently processed 
for pre-embedding light and electron microscopic immunocytochemis- 
try largely as previously described [15], but using btotinylated sheep 
anti-mouse Ig and streptavidin-biotinylated horseradish peroxtdase 
complex (Amersham) both diluted 1:lOO in 100 mM Tris-HCl pH 7.4 
with 0.3 M NaCl and 1% (v/v) newborn calf serum (without Triton). 
The antibody preparation was applied at O.ll120 pg/ml (with 10% 
newborn calf serum) for 48 h at 4*C. Cellulose nitrate/acetate filters 
(Millipore), carrying spots (ca. 0.2 ~1) of the peptides coupled to 
ovalbumin by glutaraldehyde (see above), were processed together 
with sections in order to test for crossreactivity in the immunocyto- 
chemistry conditions [2]. 
Stainmg of cell nuclei with the 9C4 antibody was seen hght micro- 
scopically in tissue which had been ~rfuslon-axed with a formalde- 
hyde/giutaraldehyde mixture (1%/2.5%) and stored in fixative. This 
staining was strongly reduced when the tissue was used shortly after 
fixation (the following day) or when the formaldehyde-glutaraldehyde 
mixture was replaced with 4% formaldehyde alone. With fresh formal- 
dehydelglutaraldehyde-fixed tissue, nuclear staining was not evident 
at concentrations of GNA-isolated IgM below 36 &ml. The follow- 
mg description is based on the use of GNA-isolated antibody (see 
above) below 36 pglml. 
3. RESULTS 
3.1. Screening of hyb$idoma~ and antibody ~pecl~city 
One clone (9C4) which was strongly positive in the 
ELISA test system produced an IgM antibody that la- 
belled specifically a 73 kDa band on immunoblots. lm- 
munoblots probed with this antibody were indistin- 
guishable from electrophoresis gels of highly purified 
protein stained with silver, and from immunoblots of 
crude or partially purified protein probed with the pol- 
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Fig. 1. Purified glutamate transporter protein (1 fig in each lane) was 
electrophoresed and visualized either directly with silver staining of 
the gel (lane 1) or, after blotting. with the 9C4 monoclonal antibody 
(lanes 2 and 3). The protein in lane 3 was treated with N-glycosidase 
F as described [15]. After deglycosylation, the relative molecular mass 
of the protein is reduced by about 10 kDa (lane 3). but he band width 
is not reduced. 
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QLT 493-506 QLT 500-514 
QLT 516-536 GLT 550-566 
GATl 564-599 PROT 3-16 
QLYT 623-638 Lysine 
GLAST 3-14 QLAST 522-541 
Fig. 2. Specificity of the 9C4 monoclonal antibody (nitrocellulose strips 611) and the polyclonal antibodies [15] (strips l-5). About 0.1~1 of the 
peptide conjugates were spotted onto strips of nitrocellulose and probed with antibodies as described in section 2. The peptides were based on the 
sequences of the two cloned glutamate transporters (GLT [16] and GLAST [17]), the glycine transporter (GLYT) [25], the GABA transporter (GAT) 
[26] and the proline transporter (PROT) [27]. The numbers indicate amino acid residue number. Strips 1, 2, 3, 4 and 5 were incubated with 0, 5, 
50, 500 and 5000 @ml of the polyclonal antibodies, respectively; while strips 10, 9, 8, 7 and 6 were incubated with 0.5, 5, 50, 500 and 5000 @ml 
of 9C4, respectively. The 9C4 antibodies react selectively with the GLT 518-536 peptide; slight crossreactivity was seen with the GLAST 3-14 
peptide (concentration for equal staining intensity more than lOOOx higher). 
yclonal antibodies (Fig. 1). Immunoblots labelled with 
the 9C4 antibody were identical to those shown in Figs. 
1, 3 and 5 in reference [15]. Thus, the monoclonal anti- 
bodies recognized a broad 73 kDa band together with 
a variable amount of high relative molecular mass mate- 
rial. The latter represents aggregates of the 73 kDa pol- 
ypeptide and is not seen when fresh brain tissue is solu- 
bilized directly in sodium dodecyl sulphate and electro- 
phoresed immediately [151. The aggregates can to some 
extent be dissolved by boiling (2 min) the protein sample 
in a solution containing sodium dodecyl sulphate (20 
mg/ml) and 2-mercaptoethanol (5% v/v) prior to elec- 
trophoresis (data not shown). When the purified protein 
was deglycosylated with N-glycosidase F as described 
[15], an equally broad band was obtained with about 10 
kDa lower relative molecular mass (Fig. 1, lane 3). Var- 
iation of glycosylation is thus not the cause of the band 
width. 
Following the cloning of two glutamate transporters, 
GLT [16] and GLAST [17] and several other trans- 
porters [25-271, 15 peptides encompassing parts of these 
proteins were synthesized. One of these peptides (GLT 
518-536) did react with the 9C4 monoclonal antibody 
(Fig. 2). This confirms that this antibody does indeed 
react with the glutamate transporter. Less than 5 ng/ml 
of the IgM is sufficient to detect this epitope in the 
spottest. A more than 1000 times increase in antibody 
concentration is required to detect crossreactivity with 
GLAST 3-14. The 9C4 antibody did not inhibit gluta- 
mate transport (data not shown). The polyclonal IgG 
antibodies reacted strongly with several of the GLT 
peptides, the main reactivity being directed against epi- 
topes different from that detected by 9C4 (Fig. 2). 
3.2. Immunocytochemical localization 
Both at the light (Fig. 3) and electron (Fig. 4) micro- 
scopic level, the staining was very similar to that ob- 
tained with the polyclonal antibodies [151. The labelling 
was (apart from what is mentioned in section 2.8) re- 
stricted to astroglia-like elements at all concentrations 
of antibody. The cells were distributed in grey as well 
as in white matter in all regions investigated: neocortex, 
hippocampus, basal ganglia, cerebellum, diencephalon, 
mesencephalon and medulla oblongata. At the light mi- 
croscopic level, the glial elements were clearly detectable 
in hippocampus at an IgM concentration of about 0.3 
&ml. At the electron microscopic level, about 10 times 
higher concentrations were necessary to obtain convinc- 
ing contrast between immunoreactive and non-im- 
munoreactive structures in uranyl and lead treated ul- 
trathin sections. At antibody concentrations of 12 pg/ml 
and higher, the staining penetrated more deeply into the 
tissue, but was not qualitatively different (Fig. 4). 
To ascertain that staining was specific under the im- 
munocytochemical conditions (higher 9C4 antibody 
concentration and different secondary antibodies than 
in Fig. 2) filters with spots of the peptide-ovalbumin 
conjugates were processed together with the sections 
(see section 2). Tested under these conditions, the 
crossreactivity with the peptide GLAST 3-14 was only 
detectable at concentrations of antibody at 36 pg/rnl 
and higher. Even at 120 pg/ml the staining was weaker 
than the staining of GLT 518-536 at an antibody con- 
centration of 1 ,@ml. None of the other conjugates 
were stained. 
At concentrations of 36 ,@ml and below of the 9C4 
antibody, the light microscopic staining of cerebellum 
was clearly weaker than the staining of hippocampus, 
other parts of the cerebrum (including neocortex) being 
intermediate. The differences in staining intensity disap- 
peared at higher concentrations of the 9C4 antibody. 
Light microscopically, delicate structures compatible 
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Fig. 3. Light microscopic localization of glutamate transporter in rat 
brain (hippocampus CAl). Note staining of astrocytes (arrows) and 
their numerous delicate processes; in the cell bodies and larger proc- 
esses, the staining is seen to follow the plasma membrane. Cell bodies 
that have been cut open by the knife at the surface of the section have 
more strongly stained processes than those situated deeper m the 
section. Symbols: white matter of the alveus (A) and corpus callosum 
(CC), stratum oriens (0). stratum pyramidale (P), stratum radiatum 
(R), perivascular processes (arrowheads) surroundmg a capillary with 
an erythrocyte (stained due to endogenous peroxidase). Formalde- 
hyde/glutaraldehyde fixation. Purified IgM 12 fig/ml. Objective x40. 
Scale bar 20 pm. 
with having fine processes of astrocytes were seen to 
pervade the neuropil in all regions. This was confirmed 
electron microscopically: the predominant site of im- 
munoreactivity was astrocytic processes (Fig. 4) while 
neurons were unstained. The unlabelled nerve terminals 
include those of glutamatergic neurons such as the ter- 
minals of hippocampal Schaffer collaterals and mossy 
fibres, which have been found to contain high affinity 
glutamate uptake sites [28]. As noted previously [15,30], 
at places of heavy labelling the diaminobenzidine reac- 
tion product tends to fill the cytoplasmic space of the 
processes probably due to diffusion from its site of for- 
mation. However, it was never seen extracellularly and 
appeared concentrated at the inner aspect of the cell 
membrane (Fig. 4). 
4. DISCUSSION 
The 9C4 monoclonal antibody shows that one epi- 
tope is sufficient to explain the staining pattern seen on 
the immunoblots. Further, when the immunoblot is 
compared to a silver stained gel of the same purified 
preparation, the protein recognized seems to be a major 
component of the purified preparation. Finally, the re- 
activity with the GLT 518-536 peptide shows that the 
9C4 antibody does react with a glutamate transporter. 
Since purified neurotransmitter transporters [31-331 
and the in vitro translated GABA transporter [27] as 
well as the glutamate transporter [161, run as wide bands 
upon electrophoresis, this migration pattern appears to 
be a molecular property of these proteins. Proteolysis 
contributes to the wideness of the glutamate transporter 
containing band. When dilute fractions of purified glu- 
tamate transporter protein are stored, there is a gradual 
shift from 73 kDa towards about 65 kDa relative molec- 
ular mass (data not shown). If the fractions are stored 
longer, the immunoreactivity gradually disappears. 
Based on the above, the report that a different mono- 
clonal antibody (Z8E9) [34], in contrast to the present 
9C4, detected a sharp, narrow band within the purified 
preparation was somewhat surprising. Unfortunately, 
the two antibodies cannot be compared under identical 
conditions because the ZSE9 antibody is no longer 
available. However, the immunocytochemical pictures 
obtained by Z8E9 and 9C4 and by our polyclonal anti- 
bodies are in agreement in that only glial cells are 
stained. (Antibody producing clone was lost after freez- 
ing - H. Koepsell, personal communication.) 
The finding that the 9C4 antibody causes plasma 
membrane associated labelling restricted to the cyto- 
plasmic side supports the proposed model for the gluta- 
mate transporter [16], in which the GLT amino acid 
residues 518-536 and 493-508 are located on one of the 
intracellular domains of the transporter. 
The GLAST protein is predominantly expressed in 
cerebellum [171 as determined by in situ hybridization 
with radioactive probes. In contrast, the finding that the 
9C4 antibody stains cerebellum less strongly than other 
parts of the brain at low to moderate concentrations 
indicates that the GLT protein is preferentially ex- 
pressed in the cerebrum, hippocampus in particular. 
Our findings suggest that (1) the electrophoretic band 
wideness of the purified preparation of the glutamate trans- 
porter is not a sign of impurities, and (2) the transporter, 
which has been isolated [14,15] and cloned [16] is located 
in glial cells and is different from neuronal subtype(s). 
A related, but different glutamate transporter assumed 
to be localized in neurons has recently been cloned [35]. 
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Fig. 4. Electron microscopic localization of glutamate transporter in rat brain (stratum radiatum of hippocampus CAl). Processes (extensions) 
of astrocytes, recognized by their characteristic irregular outlines, are heavily labelled (asterisks). The ultrastructure of the cytoplasm of labelled 
cellular components is poorly preserved due to the diaminobenzidine reaction product. This can diffuse from the place of formation before it 
precipitates, but note that it is confined to the interior of the cells. Synaptic boutons are unstained, including those cut open by the knife at the 
surface of the sections (not shown). The bouton labelled Bs and, less distinctly, several others (B) show the typical morphology of the glutamatergic 
commissural and Schaffer collateral terminals (which constitute the majority of boutons in this region [29]), forming asymmetric synaptic 
specializations on dendritic spines (D). Formaldehyde/glutaraldehyde fixation. Purified IgM 12 fig/ml. Scale bar 0.5 pm. 
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